Trial intelligence / Profile preview

Mirtazapine versus topiramate for migraine prophylaxis

IRCT20250526065900N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in migraine comparing Mirtazapine arm with Topiramate arm (2 arms). Primary endpoint: Headache severity score based on MIDAS questionnaire. Started Aug 2026; status: completed.

02

Drugs

mirtazapinetopiramate
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT20250526065900N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250526065900N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call